FOXP3 and inflammatory bowel disease: In the intestinal microenvironment of IBD patients, many key players of the immune system target otherwise harmless enteric and environmental antigens in which both FOXP3+ Tregs and Tr1 cells have lost their ability to suppress these undesired immune responses.